BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11349736)

  • 1. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg.
    Gillmore JD; Stangou AJ; Tennent GA; Booth DR; O'Grady J; Rela M; Heaton ND; Wall CA; Keogh JA; Hawkins PN
    Transplantation; 2001 Apr; 71(7):986-92. PubMed ID: 11349736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: outcome of hepatorenal transplantation.
    Testro AG; Brennan SO; Macdonell RA; Hawkins PN; Angus PW
    Liver Transpl; 2007 Jul; 13(7):1028-31. PubMed ID: 17600344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
    Booth DR; Tan SY; Booth SE; Tennent GA; Hutchinson WL; Hsuan JJ; Totty NF; Truong O; Soutar AK; Hawkins PN; Bruguera M; Caballería J; Solé M; Campistol JM; Pepys MB
    J Clin Invest; 1996 Jun; 97(12):2714-21. PubMed ID: 8675681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ transplantation in hereditary apolipoprotein AI amyloidosis.
    Gillmore JD; Stangou AJ; Lachmann HJ; Goodman HJ; Wechalekar AD; Acheson J; Tennent GA; Bybee A; Gilbertson J; Rowczenio D; O'Grady J; Heaton ND; Pepys MB; Hawkins PN
    Am J Transplant; 2006 Oct; 6(10):2342-7. PubMed ID: 16925563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.
    de Sousa MM; Vital C; Ostler D; Fernandes R; Pouget-Abadie J; Carles D; Saraiva MJ
    Am J Pathol; 2000 Jun; 156(6):1911-7. PubMed ID: 10854214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options.
    Moutafi M; Ziogas DC; Michopoulos S; Bagratuni T; Vasileiou V; Verga L; Merlini G; Palladini G; Matsouka C; Dimopoulos MA; Kastritis E
    BMC Med Genet; 2019 Jan; 20(1):23. PubMed ID: 30665372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family.
    Gillmore JD; Booth DR; Rela M; Heaton ND; Rahman V; Stangou AJ; Pepys MB; Hawkins PN
    QJM; 2000 May; 93(5):269-75. PubMed ID: 10825402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.
    Soutar AK; Hawkins PN; Vigushin DM; Tennent GA; Booth SE; Hutton T; Nguyen O; Totty NF; Feest TG; Hsuan JJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7389-93. PubMed ID: 1502149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.
    Sakata N; Hoshii Y; Nakamura T; Kiyama M; Arai H; Omoto M; Morimatsu M; Ishihara T
    J Histochem Cytochem; 2005 Feb; 53(2):237-42. PubMed ID: 15684336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
    Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26.
    Vigushin DM; Gough J; Allan D; Alguacil A; Penner B; Pettigrew NM; Quinonez G; Bernstein K; Booth SE; Booth DR
    Q J Med; 1994 Mar; 87(3):149-54. PubMed ID: 8208902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland.
    Traynor CA; Tighe D; O'Brien FJ; Leavey SF; Dorman AM; Denton MD; Magee C; Conlon PJ
    Nephrology (Carlton); 2013 Aug; 18(8):549-54. PubMed ID: 23730806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I.
    Persey MR; Booth DR; Booth SE; van Zyl-Smit R; Adams BK; Fattaar AB; Tennent GA; Hawkins PN; Pepys MB
    Kidney Int; 1998 Feb; 53(2):276-81. PubMed ID: 9461086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of amyloid proteins.
    Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
    Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.
    Holmgren G; Ericzon BG; Groth CG; Steen L; Suhr O; Andersen O; Wallin BG; Seymour A; Richardson S; Hawkins PN
    Lancet; 1993 May; 341(8853):1113-6. PubMed ID: 8097803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.
    Colombat M; Aldigier JC; Rothschild PR; Javaugue V; Desport E; Frouget T; Goujon JM; Rioux-Leclercq N; Quellard N; Rerolle JP; Paraf F; Beugnet C; Tiple A; Durrbach A; Samuel D; Brézin A; Bridoux F; Valleix S
    Kidney Int; 2020 Jul; 98(1):195-208. PubMed ID: 32571483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis.
    Horike K; Takeda A; Tsujita M; Goto N; Watarai Y; Uchida K; Katayama A; Nishihira M; Shimizu A; Nozu K; Morozumi K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():17-21. PubMed ID: 29968409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel TOF-MS Means of Quantifying ApoAI Amyloid Protein Load After Combined Liver Kidney Transplantation.
    Richards KG; Brennan SO; McCaughan GW; Chadban SJ
    Transplantation; 2018 May; 102(5):e192-e193. PubMed ID: 29377875
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.
    Rydh A; Suhr O; Hietala SO; Ahlström KR; Pepys MB; Hawkins PN
    Eur J Nucl Med; 1998 Jul; 25(7):709-13. PubMed ID: 9662592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary lysozyme amyloidosis -- phenotypic heterogeneity and the role of solid organ transplantation.
    Sattianayagam PT; Gibbs SD; Rowczenio D; Pinney JH; Wechalekar AD; Gilbertson JA; Hawkins PN; Lachmann HJ; Gillmore JD
    J Intern Med; 2012 Jul; 272(1):36-44. PubMed ID: 21988333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.